CRISM Therapeutics Corporation (CRTX) — Net Asset Momentum
CRISM Therapeutics Corporation (CRTX) recorded a net asset momentum of -4.0% as of December 2025, with net assets of GBX1.42 Million GBX. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See CRISM Therapeutics Corporation shareholders equity for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
CRISM Therapeutics Corporation Net Asset Momentum (2006–2025)
This chart tracks CRISM Therapeutics Corporation's year-over-year net asset growth across 20 annual reporting periods from 2006 to 2025. The most recent momentum reading is -4.0%, with net assets of GBX1.42 Million GBX as of December 2025. For live market cap and overall valuation, see CRISM Therapeutics Corporation (CRTX) total market value.
Annual Net Asset History for CRISM Therapeutics Corporation (2006–2025)
The table below shows the complete annual net asset history for CRISM Therapeutics Corporation from 2006 to 2025, covering 20 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check how tangible is CRISM Therapeutics Corporation's equity to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (GBX) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | GBX1.42 Million | GBX1.80 Million | GBX381.00K | ▼ -4.0% |
| 2024 | GBX1.48 Million | GBX1.82 Million | GBX341.00K | ▲ +294.2% |
| 2023 | GBX-759.66K | GBX160.53K | GBX920.19K | ▼ -103.3% |
| 2022 | GBX23.13 Million | GBX23.89 Million | GBX765.65K | ▼ -23.2% |
| 2021 | GBX30.11 Million | GBX31.24 Million | GBX1.13 Million | ▼ -4.0% |
| 2020 | GBX31.35 Million | GBX32.40 Million | GBX1.05 Million | ▲ +53.0% |
| 2019 | GBX20.48 Million | GBX21.34 Million | GBX852.24K | ▼ -12.7% |
| 2018 | GBX23.48 Million | GBX26.24 Million | GBX2.76 Million | ▼ -16.7% |
| 2017 | GBX28.20 Million | GBX29.14 Million | GBX944.00K | ▲ +10.4% |
| 2016 | GBX25.55 Million | GBX29.43 Million | GBX3.88 Million | ▲ +68.0% |
| 2015 | GBX15.21 Million | GBX15.91 Million | GBX709.20K | ▼ -26.6% |
| 2014 | GBX20.72 Million | GBX21.12 Million | GBX407.00K | ▲ +14.8% |
| 2013 | GBX18.05 Million | GBX18.13 Million | GBX74.25K | ▲ +12.0% |
| 2012 | GBX16.12 Million | GBX16.19 Million | GBX73.21K | ▼ -23.9% |
| 2011 | GBX21.19 Million | GBX21.29 Million | GBX102.00K | ▼ -0.5% |
| 2010 | GBX21.29 Million | GBX21.40 Million | GBX109.60K | ▲ +28.9% |
| 2009 | GBX16.52 Million | GBX16.81 Million | GBX289.43K | ▲ +53.2% |
| 2008 | GBX10.78 Million | GBX11.07 Million | GBX292.12K | ▲ +65.0% |
| 2007 | GBX6.53 Million | GBX6.71 Million | GBX175.32K | ▼ -30.0% |
| 2006 | GBX9.33 Million | GBX9.35 Million | GBX15.71K | — |